Advertisement
UK markets close in 4 hours 44 minutes

  • FTSE 100

    7,829.35
    -47.70 (-0.61%)
     

  • FTSE 250

    19,282.24
    -168.43 (-0.87%)
     

  • AIM

    741.09
    -4.20 (-0.56%)
     

  • GBP/EUR

    1.1670
    -0.0013 (-0.11%)
     

  • GBP/USD

    1.2438
    -0.0000 (-0.00%)
     

  • Bitcoin GBP

    51,903.61
    +2,319.42 (+4.68%)
     

  • CMC Crypto 200

    1,334.01
    +21.38 (+1.66%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CRUDE OIL

    82.22
    -0.51 (-0.62%)
     

  • GOLD FUTURES

    2,396.30
    -1.70 (-0.07%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     

  • DAX

    17,722.58
    -114.82 (-0.64%)
     

  • CAC 40

    7,997.19
    -26.07 (-0.32%)
     
Property:

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

Coronavirus-product testing group Novacyt shares surge again

Reuters - UK Focus
·1-min read

PARIS, Feb 10 (Reuters) - Shares in biotech company Novacyt , which is launching a coronavirus test, surged on Monday to extend previous big gains made this year on investor hopes it could win regulatory approval for its coronavirus test product.

Novacyt shares were up around 14% in early session trading in Paris. The stock has risen by around 300% so far in 2020.

Last week, Novacyt said it had applied for emergency approval from the U.S. Food & Drug Administration (FDA) as it races to roll out a product that tests for the coronavirus, which has killed more than 900 people. (Reporting by Sudip Kar-Gupta; Editing by Edmund Blair)